×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Quinn Anthony

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
GBIOGeneration Bio Co.Quinn Anthony G.DirectorDec 01, 2023Buy$1.4188,495124,77888,495Dec 05, 2023, 04:30 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOMar 16, 2022Buy$2.3480,079187,705550,540Mar 18, 2022, 06:46 AM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOMar 14, 2022Buy$1.9367,472130,221431,044Mar 15, 2022, 06:32 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOMar 15, 2022Buy$1.8642,41778,942473,461Mar 15, 2022, 06:32 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOMar 11, 2022Buy$2.0634,77771,780363,572Mar 15, 2022, 06:32 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEODec 09, 2021Buy$3.7043,108159,500318,269Dec 13, 2021, 08:39 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEODec 10, 2021Buy$3.7510,52639,473328,795Dec 13, 2021, 08:39 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOApr 30, 2020Buy$4.75165,000783,750538,469May 04, 2020, 07:30 AM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOOct 04, 2019Option Exercise$6.2818,265114,689371,908Oct 07, 2019, 04:09 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOJun 12, 2019Buy$6.1112,21774,705333,955Jun 14, 2019, 05:22 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOJun 13, 2019Buy$6.1714,40688,836348,361Jun 14, 2019, 05:22 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOJun 14, 2019Buy$6.235,28232,913353,643Jun 14, 2019, 05:22 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOMay 21, 2019Buy$6.8913,79494,981317,929May 22, 2019, 04:55 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOMay 22, 2019Buy$6.863,80926,128321,738May 22, 2019, 04:55 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOMay 20, 2019Buy$6.558,98958,923304,135May 22, 2019, 04:55 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOFeb 15, 2019Buy$7.107195,103277,152May 17, 2019, 05:04 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOMay 15, 2019Buy$6.766,25642,269283,408May 17, 2019, 05:04 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOMay 16, 2019Buy$6.835,52037,691288,928May 17, 2019, 05:04 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOMay 17, 2019Buy$6.656,21841,335295,146May 17, 2019, 05:04 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOFeb 06, 2019Option Exercise$6.188,75654,126276,433Feb 08, 2019, 04:15 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOFeb 15, 2018Buy$6.022,00012,04094,793Dec 10, 2018, 05:40 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEOAug 15, 2018Buy$9.139949,07595,787Dec 10, 2018, 05:40 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.President & CEODec 07, 2018Option Exercise$4.37171,890751,816267,677Dec 10, 2018, 05:40 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.Interim CEOJul 12, 2018Option Exercise$6.7638,866262,76492,793Jul 16, 2018, 09:04 AM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.Interim CEOJul 11, 2018Option Exercise$5.463,30718,05653,927Jul 13, 2018, 09:05 AM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.Interim CEOFeb 15, 2018Option Exercise$5.4615,21183,05250,620Feb 20, 2018, 12:00 AM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.Interim CEODec 06, 2017Buy$4.924,88824,07232,009Dec 08, 2017, 07:06 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.Interim CEODec 07, 2017Buy$4.992,80013,96734,809Dec 08, 2017, 07:06 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.Interim CEODec 08, 2017Buy$5.076003,03935,409Dec 08, 2017, 07:06 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.DirectorDec 05, 2017Buy$4.935,06524,97627,121Dec 05, 2017, 09:04 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.DirectorDec 01, 2017Buy$4.534,10018,57814,100Dec 05, 2017, 09:04 PM
AGLEAeglea BioTherapeutics, Inc.Quinn Anthony G.DirectorDec 04, 2017Buy$4.987,95639,62422,056Dec 05, 2017, 09:04 PM
AGLEAeglea BioTherapeutics, Inc.Quinn AnthonyDirectorApr 12, 2016Buy$10.0010,000100,00010,000Apr 12, 2016, 05:10 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO, & Head of R&DJun 22, 2015Option Exercise$78.87382,99732,675Jun 23, 2015, 10:41 AM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DApr 27, 2015Option Exercise$1.7010,00017,00015,637Apr 29, 2015, 05:28 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DApr 27, 2015Sale$110.0010,0001,100,0005,637Apr 29, 2015, 05:28 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DApr 21, 2015Sale$108.0010,0001,080,0005,637Apr 23, 2015, 07:28 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DApr 15, 2015Option Exercise$40.7410,000407,40025,637Apr 17, 2015, 05:14 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DApr 15, 2015Sale$105.0010,0001,050,00015,637Apr 17, 2015, 05:14 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DApr 06, 2015Option Exercise$76.88423,22925,637Apr 08, 2015, 06:35 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DApr 06, 2015Option Exercise$11.6919,503228,06945,140Apr 08, 2015, 06:35 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DApr 06, 2015Sale$93.7629,5032,766,20115,637Apr 08, 2015, 06:35 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DSep 02, 2014Option Exercise$23.0010,000230,00035,595Sep 04, 2014, 05:21 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DSep 02, 2014Sale$70.1410,000701,40426,995Sep 04, 2014, 05:21 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DJun 30, 2014Option Exercise$54.89713,89725,595Jul 02, 2014, 05:56 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DApr 01, 2014Option Exercise$0.9510,0009,50025,524Apr 03, 2014, 09:56 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DApr 01, 2014Option Exercise$11.9720,000239,50035,524Apr 03, 2014, 05:56 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DApr 01, 2014Sale$83.5320,0001,670,69124,849Apr 03, 2014, 05:56 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonyEVP, CMO & Head of R&DDec 31, 2013Option Exercise$36.301926,97015,524Jan 02, 2014, 07:14 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJun 28, 2013Option Exercise$35.6829710,59715,332Jul 01, 2013, 05:07 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJan 18, 2013Sale$50.089,447473,10615,035Jan 23, 2013, 05:05 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJan 18, 2013Option Exercise$0.959,4478,97524,482Jan 23, 2013, 05:05 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJan 16, 2013Option Exercise$0.9535333520,388Jan 18, 2013, 05:00 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJan 16, 2013Sale$50.075,353268,02515,035Jan 18, 2013, 05:00 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJan 17, 2013Option Exercise$0.9520019015,235Jan 18, 2013, 05:00 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJan 17, 2013Sale$50.0020010,00015,035Jan 18, 2013, 05:00 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJul 26, 2012Option Exercise$0.951,1001,04521,135Jul 30, 2012, 04:50 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJul 26, 2012Sale$50.001,10055,00020,035Jul 30, 2012, 04:50 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJul 27, 2012Option Exercise$0.956,4006,08026,435Jul 30, 2012, 04:50 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJul 27, 2012Sale$50.236,400321,50120,035Jul 30, 2012, 04:50 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJul 20, 2012Option Exercise$0.9560057020,635Jul 23, 2012, 05:10 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJul 20, 2012Sale$50.0060030,00020,035Jul 23, 2012, 05:10 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJul 19, 2012Option Exercise$0.951,9001,80521,935Jul 23, 2012, 05:10 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJul 19, 2012Sale$50.001,90095,00020,035Jul 23, 2012, 05:10 PM
GEVASYNAGEVA BIOPHARMA CORPQuinn AnthonySVP, Chief Medical OfficerJun 25, 2012Sale$40.6526,0001,056,87420,035Jun 27, 2012, 05:25 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe